Victoria Divino, PhD

Associate Principal
IQVIA

Disclosure: Seiqrus Vaccines Ltd. (Individual(s) Involved: Self): Consultant

Presentation(s):

• 6 - MF59 ASSURANCE 2: A Real-world Study to Estimate the Relative Vaccine Effectiveness of Adjuvanted Trivalent Influenza Vaccine Compared to Egg-based Trivalent High-dose Among U.S. Older Adults During 2018-19 Influenza Season

  Oral Abstract